Dongping Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dongping Chen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Thomas R. Ward
University of Basel
7 shared publications - Xiang Zhang
University of Basel
5 shared publications - Zhi Zou
Department of Chemistry, University of Basel, Basel, Switzerland
5 shared publications - Boris Lozhkin
Department of Chemistry, University of Basel, Basel, Switzerland
3 shared publications Ryo Tachibana
Department of Chemistry, University of Basel, Basel, Switzerland
3 shared publications- Daniel Gerngross
Laboratory Automation Facility, D-BSSE, ETH Zürich, Basel, Switzerland
2 shared publications
Latest Publications
- Open Access
- 28 January 2026
- Published by Springer Nature in Research Square
Biocatalytic asymmetric radical alkene hydration
Asymmetric alkene hydration provides direct access to enantiopure alcohols and has been extensively developed through ionic mechanisms. Radical pathways remain largely unexplored, despite their potential for late-stage functionalization and functional-group tolerance. In this context, the Drago-Mukaiyama hydration—which proceeds via a metal–hydride hydrogen atom transfer (MHAT) mechanism—has found numerous applications in total synthesis, yet achieving high stereocontrol remains challenging. Here we show that cytochrome P450BM3 can be repurposed as a radical hydratase that catalyzes the asymmetric radical hydration of both terminal and internal alkenes under aerobic conditions, affording a range of enantioenriched alcohols with up to 99% enantiomeric excess. Mechanistic investigations reveal a pathway initiated by metal–hydride hydrogen atom transfer (MHAT) and asymmetric intermolecular radical addition of dioxygen. A subsequent kinetic resolution of the hydroperoxide intermediate further upgrades the enantioselectivity of the alcohol product. This study highlights that radical alkene hydration can be catalyzed by haemoproteins, thus expanding the scope of challenging asymmetric reactions accessible to haemoproteins.
- 28 January 2026
- Published by Springer Nature in Research Square
Open AccessBiocatalytic asymmetric radical alkene hydration
Asymmetric alkene hydration provides direct access to enantiopure alcohols and has been extensively developed through ionic mechanisms. Radical pathways remain largely unexplored, despite their potential for late-stage functionalization and functional-group tolerance. In this context, the Drago-Mukaiyama hydration—which proceeds via a metal–hydride hydrogen atom transfer (MHAT) mechanism—has found numerous applications in total synthesis, yet achieving high stereocontrol remains challenging. Here we show that cytochrome P450BM3 can be repurposed as a radical hydratase that catalyzes the asymmetric radical hydration of both terminal and internal alkenes under aerobic conditions, affording a range of enantioenriched alcohols with up to 99% enantiomeric excess. Mechanistic investigations reveal a pathway initiated by metal–hydride hydrogen atom transfer (MHAT) and asymmetric intermolecular radical addition of dioxygen. A subsequent kinetic resolution of the hydroperoxide intermediate further upgrades the enantioselectivity of the alcohol product. This study highlights that radical alkene hydration can be catalyzed by haemoproteins, thus expanding the scope of challenging asymmetric reactions accessible to haemoproteins.
- Open Access
- 3 November 2025
- Published by Springer Nature in Nature Catalysis
- Vol. 8 (11) , 1208-1219
De novo design and evolution of an artificial metathase for cytoplasmic olefin metathesis
Artificial metalloenzymes present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Here we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis—for whole-cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo-designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (turnover number ≥1,000) and biocompatibility. This work represents a pronounced leap in the de novo design and in cellulo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- 3 November 2025
- Published by Springer Nature in Nature Catalysis
- Vol. 8 (11) , 1208-1219
Open AccessDe novo design and evolution of an artificial metathase for cytoplasmic olefin metathesis
Artificial metalloenzymes present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Here we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis—for whole-cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo-designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (turnover number ≥1,000) and biocompatibility. This work represents a pronounced leap in the de novo design and in cellulo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- 30 July 2025
- Published by Springer Nature in Nature
- Vol. 644 (8076) , 381-390
Repurposing haemoproteins for asymmetric metal-catalysed H atom transfer
Transition metal–hydrides have been widely exploited in catalysis for the hydrofunctionalization of unsaturated moieties, including carbonyls, alkenes and alkynes1. To complement heterolytic metal–hydride bond cleavage, metal–hydride hydrogen atom transfer (MHAT) has recently gained attention, as a promising strategy for radical hydrofunctionalization of unactivated alkenes2, thus enabling late-stage diversification of complex molecules3,4. However, owing to the weak interactions between the prochiral organic radical and the enantiopure catalyst5, asymmetric MHAT6 remains challenging. Here we show that cytochrome P450 enzymes (CYPs) can be repurposed to catalyse asymmetric MHAT, a new-to-nature reaction. Directed evolution of P450BM3 yielded a triple mutant that catalyses MHAT radical cyclization of unactivated alkenes, producing diverse cyclic compounds—including pyrrolidines and piperidines—with up to 98:2 enantiomeric ratio under aerobic whole-cell conditions. Apart from electron-deficient alkenes, alternative radical acceptors—including hydrazones, oximes and nitriles—were converted by repurposed P450BM3 to enantioenriched cyclization products. Mechanistic investigations support an MHAT mechanism proceeding by homolytic cleavage of a fleeting iron(III)–hydride species2,6. Starting from CYP119, directed evolution afforded a stereocomplementary MHATase, highlighting the potential of repurposed CYPs for MHAT biocatalysis. Our study highlights the prospect of integrating homolytic metal–hydride reactivity into metalloenzymes, thus expanding the scope of asymmetric radical biocatalysis.
- 30 July 2025
- Published by Springer Nature in Nature
- Vol. 644 (8076) , 381-390
Repurposing haemoproteins for asymmetric metal-catalysed H atom transfer
Transition metal–hydrides have been widely exploited in catalysis for the hydrofunctionalization of unsaturated moieties, including carbonyls, alkenes and alkynes1. To complement heterolytic metal–hydride bond cleavage, metal–hydride hydrogen atom transfer (MHAT) has recently gained attention, as a promising strategy for radical hydrofunctionalization of unactivated alkenes2, thus enabling late-stage diversification of complex molecules3,4. However, owing to the weak interactions between the prochiral organic radical and the enantiopure catalyst5, asymmetric MHAT6 remains challenging. Here we show that cytochrome P450 enzymes (CYPs) can be repurposed to catalyse asymmetric MHAT, a new-to-nature reaction. Directed evolution of P450BM3 yielded a triple mutant that catalyses MHAT radical cyclization of unactivated alkenes, producing diverse cyclic compounds—including pyrrolidines and piperidines—with up to 98:2 enantiomeric ratio under aerobic whole-cell conditions. Apart from electron-deficient alkenes, alternative radical acceptors—including hydrazones, oximes and nitriles—were converted by repurposed P450BM3 to enantioenriched cyclization products. Mechanistic investigations support an MHAT mechanism proceeding by homolytic cleavage of a fleeting iron(III)–hydride species2,6. Starting from CYP119, directed evolution afforded a stereocomplementary MHATase, highlighting the potential of repurposed CYPs for MHAT biocatalysis. Our study highlights the prospect of integrating homolytic metal–hydride reactivity into metalloenzymes, thus expanding the scope of asymmetric radical biocatalysis.
- Open Access
- 13 February 2025
- Published by Springer Nature in Research Square
De Novo Design and Evolution of an Artificial Metathase for Cytoplasmic Olefin Metathesis
Artificial metalloenzymes (ArMs) present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Herein, we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis (RCM)— for whole cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (TON ≥ 1000) and biocompatibility. This work represents a pronounced leap in the de novo design and in vivo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- 13 February 2025
- Published by Springer Nature in Research Square
Open AccessDe Novo Design and Evolution of an Artificial Metathase for Cytoplasmic Olefin Metathesis
Artificial metalloenzymes (ArMs) present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Herein, we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis (RCM)— for whole cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (TON ≥ 1000) and biocompatibility. This work represents a pronounced leap in the de novo design and in vivo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- Open Access
- 5 August 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (9) , 1184
Publisher Correction: Combining an artificial metathase with a fatty acid decarboxylase in a whole cell for cycloalkene synthesis
- 5 August 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (9) , 1184
Open AccessPublisher Correction: Combining an artificial metathase with a fatty acid decarboxylase in a whole cell for cycloalkene synthesis
- 19 July 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (10) , 1656-1664
An evolved artificial radical cyclase enables the construction of bicyclic terpenoid scaffolds via an H-atom transfer pathway
While natural terpenoid cyclases generate complex terpenoid structures via cationic mechanisms, alternative radical cyclization pathways are underexplored. The metal-catalysed H-atom transfer reaction (M-HAT) offers an attractive means for hydrofunctionalizing olefins, providing access to terpenoid-like structures. Artificial metalloenzymes offer a promising strategy for introducing M-HAT reactivity into a protein scaffold. Here we report our efforts towards engineering an artificial radical cyclase (ARCase), resulting from anchoring a biotinylated [Co(Schiff-base)] cofactor within an engineered chimeric streptavidin. After two rounds of directed evolution, a double mutant catalyses a radical cyclization to afford bicyclic products with a cis-5-6-fused ring structure and up to 97% enantiomeric excess. The involvement of a histidine ligation to the Co cofactor is confirmed by crystallography. A time course experiment reveals a cascade reaction catalysed by the ARCase, combining a radical cyclization with a conjugate reduction. The ARCase exhibits tolerance towards variations in the dienone substrate, highlighting its potential to access terpenoid scaffolds.
- 19 July 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (10) , 1656-1664
An evolved artificial radical cyclase enables the construction of bicyclic terpenoid scaffolds via an H-atom transfer pathway
While natural terpenoid cyclases generate complex terpenoid structures via cationic mechanisms, alternative radical cyclization pathways are underexplored. The metal-catalysed H-atom transfer reaction (M-HAT) offers an attractive means for hydrofunctionalizing olefins, providing access to terpenoid-like structures. Artificial metalloenzymes offer a promising strategy for introducing M-HAT reactivity into a protein scaffold. Here we report our efforts towards engineering an artificial radical cyclase (ARCase), resulting from anchoring a biotinylated [Co(Schiff-base)] cofactor within an engineered chimeric streptavidin. After two rounds of directed evolution, a double mutant catalyses a radical cyclization to afford bicyclic products with a cis-5-6-fused ring structure and up to 97% enantiomeric excess. The involvement of a histidine ligation to the Co cofactor is confirmed by crystallography. A time course experiment reveals a cascade reaction catalysed by the ARCase, combining a radical cyclization with a conjugate reduction. The ARCase exhibits tolerance towards variations in the dienone substrate, highlighting its potential to access terpenoid scaffolds.
- 27 June 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (9) , 1113-1123
Combining an artificial metathase with a fatty acid decarboxylase in a whole cell for cycloalkene synthesis
- 27 June 2024
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (9) , 1113-1123
Combining an artificial metathase with a fatty acid decarboxylase in a whole cell for cycloalkene synthesis